ALHC — Alignment Healthcare, Inc. Healthcare · Healthcare Plans NASDAQ
$17.93
1D 5D 1M 3M 6M YTD 1Y 5Y MAX
Income Statement Balance Sheet Cash Flow
Annual · All values in US Dollars (USD)
USD FY2025 FY2024 FY2023 FY2022 Revenue 3.95B 2.70B 1.82B 1.43B YoY Growth +46.1% +48.3% +27.2% — Gross Profit 488.56M 296.69M 201.03M 184.28M Gross Margin 12.4% 11.0% 11.0% 12.8% R&D — — — — SG&A 443.41M 371.37M 307.43M 295.65M EBIT 14.75M (101.56M) (127.82M) (128.64M) EBIT Margin 0.4% -3.8% -7.0% -9.0% D&A 30.48M 27.06M 21.67M 17.49M EBITDA 45.32M (77.44M) (105.30M) (113.53M) EBITDA Margin 1.1% -2.9% -5.8% -7.9% Net Income (724,000) (128.03M) (148.02M) (149.55M) Net Margin -0.0% -4.7% -8.1% -10.4% EPS (diluted) — -$0.67 -$0.79 -$0.83 Shares (dil., M) — 191 186 181
Company Brief
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Margins (TTM)
Gross Margin 12.4% EBITDA Margin 1.6% EBIT Margin 0.8% Net Margin 0.5% FCF Margin 5.3%
Returns on Capital
ROIC 7.0% ROCE 7.0% ROE 11.0% ROA 1.9% Asset Turnover 3.99×
Earnings Quality
FCF / Net Income — SBC / Net Income — SBC / Revenue 1.6% Capex / D&A 0.88×
Growth (CAGR)
Metric 3yr Revenue 40.2% EPS — FCF — Dividend —
Ownership
Float 82.4% Shares Out. 206.7M Insiders % 3.1% Institutions % 111.1% Institutions (of float) 114.7% Institution holders 383 Insider net buy 6M -0.8%
Balance Sheet
Cash & ST Invest. $604.2M Total Debt $329.6M Net Cash / (Debt) $246.2M Total Assets $1.1B Total Equity $179.3M Goodwill & Intang. $36.6M Tangible Book Value $142.7M NCAV (Graham) $65.1M Tangible Book/sh $0.69 NCAV/sh $0.31
Leverage
D/E Ratio 1.84× Net Debt / EBITDA -3.70× Interest Coverage 2.24× Current Ratio 1.71× Quick Ratio 1.71×
Capital Allocation (last FY)
Capex $26.8M Capex / Revenue 0.7% SBC $62.1M Dividends Paid — Buybacks —
Dividends
No dividend paid.
Valuation vs History
P/E vs 4Y 202.6× Div yield vs 10Y —
Buyback History
FY 2025 — +6.5%
FY 2024 — +1.5%
FY 2023 — +0.9%
FY 2022 — —
Margins (TTM)
Gross Margin 12.4% EBITDA Margin 1.6% EBIT Margin 0.8% Net Margin 0.5% FCF Margin 5.3%
Returns on Capital
ROIC 7.0% ROCE 7.0% ROE 11.0% ROA 1.9% Asset Turnover 3.99×
Earnings Quality
FCF / Net Income — SBC / Net Income — SBC / Revenue 1.6% Capex / D&A 0.88×
Growth (CAGR)
Metric 3yr Revenue 40.2% EPS — FCF — Dividend —
Ownership
Float 82.4% Shares Out. 206.7M Insiders % 3.1% Institutions % 111.1% Institutions (of float) 114.7% Institution holders 383 Insider net buy 6M -0.8%
$17.93
1D 5D 1M 3M 6M YTD 1Y 5Y MAX
Income Statement Balance Sheet Cash Flow
Annual · All values in US Dollars (USD)
USD FY2025 FY2024 FY2023 FY2022 Revenue 3.95B 2.70B 1.82B 1.43B YoY Growth +46.1% +48.3% +27.2% — Gross Profit 488.56M 296.69M 201.03M 184.28M Gross Margin 12.4% 11.0% 11.0% 12.8% R&D — — — — SG&A 443.41M 371.37M 307.43M 295.65M EBIT 14.75M (101.56M) (127.82M) (128.64M) EBIT Margin 0.4% -3.8% -7.0% -9.0% D&A 30.48M 27.06M 21.67M 17.49M EBITDA 45.32M (77.44M) (105.30M) (113.53M) EBITDA Margin 1.1% -2.9% -5.8% -7.9% Net Income (724,000) (128.03M) (148.02M) (149.55M) Net Margin -0.0% -4.7% -8.1% -10.4% EPS (diluted) — -$0.67 -$0.79 -$0.83 Shares (dil., M) — 191 186 181
Company Brief
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Balance Sheet
Cash & ST Invest. $604.2M Total Debt $329.6M Net Cash / (Debt) $246.2M Total Assets $1.1B Total Equity $179.3M Goodwill & Intang. $36.6M Tangible Book Value $142.7M NCAV (Graham) $65.1M Tangible Book/sh $0.69 NCAV/sh $0.31
Leverage
D/E Ratio 1.84× Net Debt / EBITDA -3.70× Interest Coverage 2.24× Current Ratio 1.71× Quick Ratio 1.71×
Capital Allocation (last FY)
Capex $26.8M Capex / Revenue 0.7% SBC $62.1M Dividends Paid — Buybacks —
Dividends
No dividend paid.
Valuation vs History
P/E vs 4Y 202.6× Div yield vs 10Y —
Buyback History
FY 2025 — +6.5%
FY 2024 — +1.5%
FY 2023 — +0.9%
FY 2022 — —
Not investment advice Updated 4/17/2026
